Missile ‘megatrend' still underestimated despite Iran conflict, says Citi

Citi says recent Middle East events have reinforced a multi‑year missile and interceptor demand megatrend and that consensus growth forecasts remain too conservative, naming RTX, L3Harris, Lockheed Martin, Karman Holdings and Ducommun as particularly exposed. Analysts highlight disclosed production targets for AMRAAM, SM‑3, SM‑6, Tomahawk, PAC‑3 and THAAD set to rise roughly 2–4x over the next five to seven years, and the US fiscal‑2026 budget ramps missile defence to $40.2bn (from $13.5bn in FY2025) with $35.7bn for missiles and munitions; however Jefferies warns capacity and supply‑chain stress—not demand—is the key constraint. Market reaction was modestly negative intraday (RTX -2.4%, L3Harris & Lockheed ≈ -1.95%, Northrop -0.8%) but multi‑day gains point to investor interest while execution risks around sustained production ramps persist.

Analysis

Winners are large primes (RTX, LMT) and tier-1 suppliers (LHX, NOC, KRMN, DCO) because demand is structural: FY2026 US budgets allocate $40.2bn to missile defence (vs $13.5bn in FY2025) and programmes (AMRAAM, SM‑3/6, Tomahawk, PAC‑3, THAAD) plan 2–4x production over the next 5–7 years. Losers include commercial aerospace and smaller subcontractors unable to finance the capex/labor ramp; margins at lower‑tier suppliers may compress as they underprice to secure long-term awards.

Competitive dynamics favour primes with vertical scale and defense relationships—pricing power on framework re‑negotiations can lift margins if framework agreements are definitized with improved economics; however capacity is the choke point, so expect multi-year lead times for revenue recognition and concentrated award flow to incumbents. Supply/demand is demand‑heavy but capacity‑constrained: inventory rebuilds and supplier CAPEX cycles (12–36 months) become the gating factor.

Cross-asset: higher sustained defense spend increases Treasury issuance and could push real yields +20–75bp over 6–12 months, pressuring rate‑sensitive industrials; USD likely to strengthen on flight‑to‑safety and higher rates; oil and base metals spike on geopolitical escalation, adding input‑cost risk. Tail risks: rapid regional escalation, sanctions on non‑US suppliers, or supply‑chain cyber incidents could sharply re‑price names within days; catalysts to watch are contract awards, DoD budget appropriations, and quarterly production-rate disclosures.

Consensus underestimates the time and capex required to ramp 2–4x production—market may be underpricing multi‑year revenue upside for primes but overpricing short‑term earnings; conversely, if awards are backloaded or politics shifts, expect 10–30% downside in smaller suppliers. Trade execution should be staged: capture multi‑year upside with limited upfront option spend, size selectively (2–4% long per prime) and use clear stop/profit triggers tied to contract news and yield moves.

Key Decisions for Investors

• Establish a 2.5% portfolio long in RTX (NYSE:RTX) via a 12‑month call spread (buy 10–15% OTM call, sell 30–40% OTM call) to capture multi‑year missile demand while capping premium; trim half on a +25% move or if a material contract is not definitized within 6 months.
• Add a 2% long in LMT (NYSE:LMT) with a 9–15 month covered-call/call‑spread structure (buy 1x share exposure + sell 6–9 month 10% OTM calls) to harvest yield while owning prime‑contract optionality; exit if Treasury 10y yield rises >50bp in 30 days or if DoD awards are reduced.
• Small tactical 1–1.5% longs in LHX (L3Harris) and KRMN (Karman) as supply‑chain leverages; use outright equity for LHX and a protective‑put (3–6 month, 7–10% OTM) on KRMN; reduce positions if supplier margin guidance deteriorates sequentially.
• Relative value: pair trade long LHX (1.5%) vs short NOC (1.0%) to express supplier outperformance vs larger systems integrator where upside is already priced; target 12–18 month horizon, close if spread narrows <5% or widens >20%.
• Monitor (do not trade blindly) contract definitizations, FY2027 DoD hearings, and quarterly production targets over next 30–180 days; act to add on confirmed multi‑year award disclosure or cut exposure if any single‑contract cancellation >$500m is reported.